David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Crown Castle
CCI
$32.2B
| $6.61M | ﹤0.01% |
87,239
+76,674
| +726% | +$6.73M |
|
2077
CALL
Novartis
NVS
$303B
| $6.58M | ﹤0.01% |
42,000
+1,700
| +4% | +$255K |
|
2078
Atlas Energy Solutions
AESI
$1.52B
| $6.57M | ﹤0.01% |
+395,772
| New | +$6.47M |
|
2079
Insperity
NSP
$1.98B
| $6.57M | ﹤0.01% |
158,989
-218,749
| -58% | -$7.17M |
|
2080
Healthcare Services Group
HCSG
$1.56B
| $6.52M | ﹤0.01% |
265,647
-84,419
| -24% | -$1.78M |
|
2081
Dorman Products
DORM
$3.86B
| $6.5M | ﹤0.01% |
47,662
-96,321
| -67% | -$11.4M |
|
2082
CALL
Group 1 Automotive
GPI
$3.11B
| $6.49M | ﹤0.01% |
22,300
-2,300
| -9% | -$754K |
|
2083
CALL
McCormick & Company Non-Voting
MKC
$14.7B
| $6.49M | ﹤0.01% |
128,700
+92,400
| +255% | +$4.53M |
|
2084
PUT
GitLab
GTLB
$6.9B
| $6.48M | ﹤0.01% |
212,100
-18,900
| -8% | -$479K |
|
2085
Nuvation Bio
NUVB
$2.44B
| $6.48M | ﹤0.01% |
1,140,000
+747,014
| +190% | +$3.65M |
|
2086
Expro Ltd
XPRO
$1.99B
| $6.47M | ﹤0.01% |
+438,291
| New | +$7.04M |
|
2087
Universal Display
OLED
$3.94B
| $6.46M | ﹤0.01% |
74,584
-29,600
| -28% | -$2.73M |
|
2088
PUT
Bunge Global
BG
$21.3B
| $6.44M | ﹤0.01% |
+60,300
| New | +$7.41M |
|
2089
PUT
General Motors
GM
$76B
| $6.43M | ﹤0.01% |
83,400
-183,600
| -69% | -$14.4M |
|
|
TECX
2090
Tectonic Therapeutic
TECX
$735M
| $6.41M | ﹤0.01% |
186,550
+70,430
| +61% | +$2.07M |
|
2091
CALL
Ferrari
RACE
$74.4B
| $6.4M | ﹤0.01% |
17,200
-18,600
| -52% | -$6.47M |
|
2092
Lincoln Electric
LECO
$15.2B
| $6.4M | ﹤0.01% |
24,113
+20,059
| +495% | +$5.25M |
|
2093
LG Display
LPL
$3.34B
| $6.39M | ﹤0.01% |
1,642,836
+787,072
| +92% | +$3.61M |
|
2094
Fox Class B
FOX
$25.8B
| $6.39M | ﹤0.01% |
136,401
-4,979
| -4% | -$277K |
|
2095
PUT
Ross Stores
ROST
$77.5B
| $6.39M | ﹤0.01% |
30,000
| – | – |
|
2096
Gold Royalty Corp
GROY
$816M
| $6.38M | ﹤0.01% |
2,311,195
-1,652,300
| -42% | -$5.45M |
|
2097
Fox Factory Holding Corp
FOXF
$886M
| $6.36M | ﹤0.01% |
375,488
-35,594
| -9% | -$619K |
|
2098
Atlanta Braves Holdings Series B
BATRK
$3.39B
| $6.35M | ﹤0.01% |
122,423
+63,555
| +108% | +$3.12M |
|
2099
CG Oncology
CGON
$6.98B
| $6.35M | ﹤0.01% |
89,417
+42,807
| +92% | +$2.8M |
|
2100
PennyMac Financial
PFSI
$3.87B
| $6.33M | ﹤0.01% |
+72,721
| New | +$6.32M |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.